MorphoSys’s emphasis on its clinical-stage cancer programs puts the spotlight on a myelofibrosis drug candidate from its 2021 acquisition of Constellation Pharmaceuticals. That small molecule could compete against drug candidates from GSK and Merck.
Pfizer Inc is in early-stage talks to acquire cancer drugmaker Seagen Inc in a potential multi-billion dollar deal, the Wall Street Journal reported, after..
/PRNewswire/ The "Polycythemia Vera Market Insight, Epidemiology and Market Forecast -2032" report has been added to ResearchAndMarkets.com s offering. This.